Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,654,380 papers from all fields of science
Search
Sign In
Create Free Account
Enoxaparin
Known as:
Enoxaparin [Chemical/Ingredient]
, Enoxaparine
A low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
30 relations
0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe
0.6 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]
0.8 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]
Angina, Unstable
Expand
Broader (2)
Anticoagulants
Fibrinolytic Agents
Narrower (5)
Clexane
EMT-966
Enoxaparin sodium
Lovenox
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Incidence and predictors of bleeding complications
Magdalena Doktorova
,
Z. Motovska
2013
Corpus ID: 11395049
Selective coronary angiography as a diagnostic method followed by percutaneous coronary intervention (PCI) as a therapeutic…
Expand
2012
2012
A prospective cohort study of fibula free flap donor-site morbidity in 157 consecutive patients.
J. V. Ver Halen
Plastic and Reconstructive Surgery
2012
Corpus ID: 205971924
2011
2011
Problems in dealing with very rare adverse effects of new anticancer drugs: the example of trabectedin.
F. Grosso
,
M. D’Incalci
Tumori
2011
Corpus ID: 11962703
To the Editor: The paper by Stoyianni et al.1 reports a case of rhabdomyolysis in a uterine leiomyosarcoma patient treatedwith…
Expand
2009
2009
Helmet to deliver noninvasive ventilation: "Handle with care".
S. Nava
,
P. Navalesi
Critical Care Medicine
2009
Corpus ID: 29112916
2008
2008
AVE5026: A new hemisynthetic ultra low molecular weight heparin (ULMWH) with enriched anti-Xa activity and enhanced antithrombotic activity for management of cancer associated thrombosis
D. Hoppensteadt
,
W. Jeske
,
Walenga Jm
,
J. Fareed
2008
Corpus ID: 75217107
2005
2005
Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes.
C. Wong
,
H. White
European Heart Journal
2005
Corpus ID: 36154123
This editorial refers to ‘TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization…
Expand
2000
2000
Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators.
Young Jj
,
Kereiakes Dj
,
Grines Cl
The Journal of invasive cardiology
2000
Corpus ID: 196456406
Early coronary intervention in patients with non-ST segment elevation acute coronary syndromes (ACS) may be facilitated by…
Expand
1998
1998
Ketorolac and Enoxaparin Affect Arterial Thrombosis and Bleeding in the Rabbit
S. Delaporte-Cerceau
,
C. Samama
,
B. Riou
,
P. Bonnin
,
J. Guillosson
,
P. Coriat
Anesthesiology
1998
Corpus ID: 38458177
Background Nonsteroidal anti‐inflammatory drugs (NSAIDs) may interfere with hemostasis during the perioperative period, and the…
Expand
1997
1997
The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin.
P. Nilsson
,
D. Bergqvist
,
+5 authors
G. Nylander
Orthopedics
1997
Corpus ID: 42571976
ABSTRACTThis prospective, double-blind trial was performed to determine whether 4 weeks' prophylaxis with enoxaparin after total…
Expand
1997
1997
Evaluation of Enoxaparin Given before and after Operation to Prevent Venous Thromboembolism during Digestive Surgery: Play-the-Winner Designed Study
O. Bjerkeset
,
S. Larsen
,
O. Reiertsen
World Journal of Surgery
1997
Corpus ID: 11412613
Abstract A total of 316 patients were included in a play-the-winner (PTW) designed study comparing the safety of enoxaprain…
Expand